Published in Int J Clin Pract on January 01, 2009
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med (2011) 1.25
The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial. Trials (2010) 0.88
Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes (2013) 0.86
Economic burden of chronic bronchitis in the United States: a retrospective case-control study. Int J Chron Obstruct Pulmon Dis (2011) 0.82
Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Phenotypic Variation in Patients with Chronic Obstructive Pulmonary Disease in Primary Care. Biomed Res Int (2016) 0.75
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet (2004) 6.17
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Respir Crit Care Med (1996) 5.82
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest (2003) 2.90
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest (2000) 2.83
The burden and impact of COPD in Asia and Africa. Int J Tuberc Lung Dis (2004) 2.83
Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J (2006) 2.74
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J (2007) 1.99
Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis (1993) 1.87
Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest (2002) 1.83
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.76
[Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. Arch Bronconeumol (2004) 1.62
Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med (2002) 1.27
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.23
The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1988) 1.22
Epidemiology and global impact of chronic obstructive pulmonary disease. Semin Respir Crit Care Med (2005) 1.14
How should health-related quality of life be assessed in patients with COPD? Chest (2000) 1.11
Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.02
Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease. COPD (2004) 1.02
The burden of COPD in Spain: results from the Confronting COPD survey. Respir Med (2003) 0.97
COPD: problems in diagnosis and measurement. Eur Respir J Suppl (2003) 0.97
Management of severe COPD. Lancet (2004) 0.95
Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease. Am J Med (1993) 0.91
[Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC)]. Arch Bronconeumol (2005) 0.81
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol (1997) 4.08
Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science (1999) 3.96
Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science (1999) 3.41
Vertical strabismus after cataract surgery. Ophthalmology (1996) 2.56
Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis (1994) 2.04
[Cervical cancer screening. False negative smears]. Rev Med Suisse Romande (1997) 1.94
[Prevalence of antibodies against hepatitis C virus in a sample of homosexual males]. Med Clin (Barc) (1993) 1.94
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Br J Cancer (2013) 1.85
Antidiarrhoeic activity of Euphorbia hirta extract and isolation of an active flavonoid constituent. Planta Med (1993) 1.74
[Pacemaker implantation in a patient with persistent left superior vena cava and atresia of the right superior vena cava]. Rev Port Cardiol (1994) 1.66
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med (1995) 1.58
Electrostatic force microscopy on oriented graphite surfaces: coexistence of insulating and conducting behaviors. Phys Rev Lett (2006) 1.58
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth (2011) 1.55
Free radical scavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med (1993) 1.54
Nutritional value and antigenicity of two milk protein hydrolysates in rats and guinea pigs. J Nutr (1994) 1.51
[Clinical practice guideline based on the evidence for the management of sedoanalgesia in the critically ill adult patient]. Med Intensiva (2007) 1.48
Porokeratotic eccrine ostial and dermal duct naevus. Br J Dermatol (1995) 1.48
[Usefulness of computerized tomography and bronchoscopy in patients with hemoptysis. Analysis of 482 cases]. An Med Interna (2002) 1.45
[Transesophageal echocardiography in mitral prosthesis dysfunction: usefulness and limitations in the evaluation of mitral insufficiency]. Rev Esp Cardiol (1993) 1.40
Differential intraocular pressure in restrictive strabismus. Am J Ophthalmol (1991) 1.40
[Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission]. Med Clin (Barc) (2000) 1.39
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status. Int J Tuberc Lung Dis (2008) 1.38
[Usefulness of carcinoembryonic antigen and other markers in patients with hemoptysis]. An Med Interna (2000) 1.38
Use of buccal fat pad to repair intraoral defects: review of 30 cases. Br J Oral Maxillofac Surg (1997) 1.37
[The 2013 Seville Consensus Document on alternatives to allogenic blood transfusion. An update on the Seville Document]. Rev Esp Anestesiol Reanim (2013) 1.37
Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth (2008) 1.36
Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev (2006) 1.30
Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J Virol (2001) 1.22
Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients. J Infect Dis (1986) 1.20
Antidiarrhoeic activity of quercitrin in mice and rats. J Pharm Pharmacol (1993) 1.19
HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era. Int J Tuberc Lung Dis (2012) 1.19
Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acids Res (1999) 1.19
Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen Pharmacol (1993) 1.18
Changes of ploidy during the Azotobacter vinelandii growth cycle. J Bacteriol (1994) 1.17
Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol (1998) 1.17
Outcome of surgical management of superior oblique palsy: a study of 123 cases. Binocul Vis Strabismus Q (1998) 1.16
Evaluation of an absorbable synthetic suture material. Surg Gynecol Obstet (1970) 1.15
The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment Pharmacol Ther (2011) 1.15
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS (1998) 1.14
Computer graphic display method for visualizing three-dimensional biological structures. Science (1986) 1.14
Cortical projections of the non-entorhinal hippocampal formation in the cynomolgus monkey (Macaca fascicularis). Eur J Neurosci (2001) 1.14
Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS (1998) 1.14
Clinicopathologic features of a systemic coronavirus-associated disease resembling feline infectious peritonitis in the domestic ferret (Mustela putorius). Vet Pathol (2008) 1.14
Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol (1994) 1.13
The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg (1998) 1.13
Establishment of 2-docosanol as a cellular marker compound in the identification of Mycobacterium xenopi. J Clin Microbiol (1989) 1.13
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol (1996) 1.13
Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol (1993) 1.12
Plasmacytoid dendritic cells reduce HIV production in elite controllers. J Virol (2012) 1.09
Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods. J Viral Hepat (1994) 1.08
Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge. J Cell Sci (2000) 1.07
Topographical and laminar distribution of cortical input to the monkey entorhinal cortex. J Anat (2007) 1.07
Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients. J Clin Virol (2005) 1.07
CNS complications in acute malaria: MR findings. AJNR Am J Neuroradiol (1993) 1.07
Takayasu arteritis in Colombia. Int J Cardiol (1998) 1.04
C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis. Anticancer Res (1996) 1.03
Energy-dispersive absorption spectroscopy for hard-X-ray micro-XAS applications. J Synchrotron Radiat (2006) 1.03
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg (1999) 1.03
An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals. AIDS (1993) 1.02
Analysis of rotavirus nonstructural protein NSP5 phosphorylation. J Virol (1998) 1.02
A quantitative immunofluorescence test for the detection of anti-Candida antibodies. J Immunol Methods (1980) 1.01
The budding yeast Cdc15 localizes to the spindle pole body in a cell-cycle-dependent manner. Mol Cell Biol Res Commun (2000) 1.00
Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. Gen Pharmacol (1996) 1.00
CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol (2000) 0.99
Serum and tissue trace metal levels in lung cancer. Oncology (1989) 0.99
Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J Pathol (1997) 0.99
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfus Med (2006) 0.98
Intraspecific variation in retinal cone distribution in the bluefin killifish, Lucania goodei. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2003) 0.98
Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol (1997) 0.97
Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex. J Chem Neuroanat (2003) 0.97
Postoperative blood salvage and reinfusion in spinal surgery: blood quality, effectiveness and impact on patient blood parameters. Eur Spine J (2000) 0.96
Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis (1995) 0.96
p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J Pathol (1998) 0.96
The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clin Transl Oncol (2007) 0.95
[Compliance with tuberculosis treatment in adults in Santiago, Chile]. Bol Oficina Sanit Panam (1991) 0.95
Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang (2005) 0.95
A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev (2006) 0.95
[Ureteral duplications with a blind branch. Apropos of 4 cases]. An Esp Pediatr (1986) 0.95
Amino acid sequence and structural properties of protein p12, an African swine fever virus attachment protein. J Virol (1992) 0.95
Hepatitis C virus replication in Caucasian HIV controllers. J Viral Hepat (2011) 0.94
Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol (1993) 0.93
Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. Acta Neurol Scand (2009) 0.93
C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients. Anticancer Res (1999) 0.93
Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation (1994) 0.93
Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol (2004) 0.93
[Psychometric validation of translation to Spanish of the gastrointestinal symptoms rating scale (GSRS) and quality of life in reflux and dyspepsia (QOLRAD) in patients with gastroesophageal reflux disease]. Rev Clin Esp (2005) 0.92
A new focus of cutaneous leishmaniasis due to Leishmania amazonensis in a Sub Andean region of Bolivia. Acta Trop (1998) 0.92
Virological and immunological characteristics of HIV treatment failure. AIDS (2000) 0.92
Generalized pustular psoriasis and idiopathic hypoparathyroidism. Arch Dermatol (1991) 0.92
Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors. Med Oncol (2013) 0.91
Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus. J Pharmacol Exp Ther (1997) 0.91
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group. AIDS (2000) 0.91
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat (2004) 0.90
Prevalence of gastro-oesophageal reflux disease in Spain and associated factors. Aliment Pharmacol Ther (2006) 0.90
Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts. Eur J Clin Microbiol Infect Dis (2001) 0.89
Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis (1998) 0.89
Using molecular markers to assess the effect of introgression on quantitative attributes of common bean in the Andean gene pool. Theor Appl Genet (2003) 0.89
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain. AIDS (2001) 0.89